300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Email
Payments
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Hospitality
Legal
eSports
Construction
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Theatre
Cannabis
LGBT
Celebrity
Medical
Climate
Mobile Apps
Life Science
Recruiting
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Web3
Sporting Goods
Manufacturing
Digital Media
Financial Services
FinTech
Finance
Franchise
Social Media
Mobile Advertising
Non Profit
Android
Internet
Sustainability
Hardware
Biotech
Enterprise
Impact
Proptech
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Mexico
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Nigeria
Tajikistan
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Romania
Pakistan
Oman
Poland
Puerto Rico
Sudan
Cameroon
Guernsey
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Australia
Uzbekistan
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Switzerland
Jamaica
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Guatemala
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Canada
Tanzania
United Kingdom
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Belgium
Barbados
Jordan
Bangladesh
Austria
Ethiopia
Azerbaijan
Bulgaria
Bahamas
Ecuador
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Finland
Italy
Algeria
Belize
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Cambodia
Lebanon
Honduras
Lithuania
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Startup Investors in Austria (August 2026)

The most active venture capital funds and angel investors investing in Austria Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Austria Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
XISTA Science Ventures
VC Fund
17 Austria, Germany, France Seed, Pre-Seed, Series A Biotechnology, Medical, Software $511k–$20M
tecnet equity
VC Fund
9 Austria Seed, Series A Software, Biotechnology, Health Care $400k–$20M
xista science ventures
VC Fund
9 Austria, Slovenia Seed, Pre-Seed, Series A Biotechnology, Medical, Software $511k–$20M
austria Wirtschaftsservice (aws)
VC Fund
6 Austria, Belgium Seed, Grant, Pre-Seed Software, Information Technology, Artificial Intelligence $62k–$2.8M
SOSV
VC Fund
5 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
MIG Capital
VC Fund
4 Germany, France, Austria Series A, Series B Biotechnology, Health Care, Software $1.6M–$60M
aws Gründungsfonds
VC Fund
4 Austria, Germany, United States Seed, Series A Software, SaaS, Information Technology $1.1M–$11M
FPS-Holding
VC Fund
3 Austria Seed Biotechnology, Health Diagnostics $420k–$1.5M
Lansdowne Partners
VC Fund
3 United Kingdom, Austria, United States Series A, Series B Biotechnology, Finance, Genetics $6.7M–$100M
Schnidar Harald
Angel
3 Austria Seed, Angel, Pre-Seed mHealth, Software, Biopharma
PUSH VC
VC Fund
3 Austria, Germany, United States Seed, Series A Software, Apps, Health Care $650k–$31M
10x Founders
VC Fund
3 Germany, United States, Switzerland Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $1.1M–$60M
BackBone Ventures
VC Fund
2 Switzerland, Germany, Israel Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $578k–$105M
Verge HealthTech Fund
VC Fund
2 Estonia, Singapore, United Kingdom Seed, Pre-Seed, Series A Health Care, Medical Device, Medical $500k–$4.7M
Simon Capital
VC Fund
2 Germany, Austria, The Netherlands Series A, Seed, Series B Software, Biotechnology, Food and Beverage $1.7M–$57M
Nina Capital
VC Fund
2 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $529k–$21M
APEX Ventures
VC Fund
2 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $511k–$28M
KHAN Technology Transfer Fund
VC Fund
2 Germany, Austria, Luxembourg Seed, Pre-Seed, Series A Biotechnology, Medical, Biopharma $259k–$10M
Arax Capital Partners
VC Fund
2 Austria Seed Biotechnology, Health Care, SaaS $1.1M–$1.1M
Hadean Ventures
VC Fund
2 Norway, Sweden, Austria Series A, Series B Biotechnology, Health Care, Medical $4.3M–$79M
Longevitytech.fund
VC Fund
2 United States, United Kingdom, The Netherlands Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Life Science $100k–$10M
red-stars.com
VC Fund
2 Austria, Germany Seed, Series A Software, Biotechnology, Telecommunications $1.8M–$4.4M
Ligand Pharmaceuticals
VC Fund
2 United States, Austria, Denmark Post-IPO Debt, Corporate Round, Post-IPO Equity Biotechnology, Medical, Health Care $3M–$90M
The Austrian Research Promotion Agency (FFG)
VC Fund
2 Austria, United States, Belgium Grant, Seed, Pre-Seed Software, Artificial Intelligence, Medical $67k–$3.5M
ICL Planet Startup Hub
VC Fund
2 Israel, Austria Seed Biotechnology, Agriculture, AgTech $4.3M–$10M
R42 Group
VC Fund
2 United Kingdom, United States, Austria Seed, Pre-Seed, Series A Biotechnology, Health Care, Software $472k–$40M
bmp Ventures
VC Fund
2 Germany, United States, Austria Seed, Series A Software, Information Technology, Manufacturing $30k–$5.9M
Open Field Capital
VC Fund
2 United States, Austria, United Kingdom Series A, Seed Artificial Intelligence, Software, Health Care $3.1M–$52M
Übermorgen Ventures
VC Fund
2 Germany, Switzerland, Finland Seed, Pre-Seed, Series A Energy, Software, SaaS $300k–$12M
Aescap Venture
VC Fund
2 United Kingdom, Austria, Belgium Series A, Series B Biotechnology, Pharmaceutical, Chemical $1.5M–$33M
TSVC
VC Fund
2 United States, China, Canada Seed, Series A Software, Artificial Intelligence, Health Care $500k–$55M
HTGF (High-Tech Gruenderfonds)
VC Fund
2 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $909k–$39M
Gamma Capital Partners
VC Fund
2 Austria, United States, Germany Series A, Seed Software, Manufacturing, Information Technology $406k–$8M
SkyGene
VC Fund
2 Austria Venture - Series Unknown Medical, Health Care, Biotechnology
GreyBird Ventures
VC Fund
2 United States, China, Israel Series A, Seed Health Care, Medical, Biotechnology $3M–$16M
VP Venture Partners
VC Fund
2 Austria, Switzerland Seed Medical, Health Diagnostics, Internet $3M–$6.9M
eQventure
VC Fund
2 Austria, Germany, Switzerland Seed, Series A Software, Information Technology, Artificial Intelligence $540k–$6.3M
MCI Capital SA
VC Fund
1 Poland, Germany, United Kingdom Series A, Seed E-Commerce, Software, Mobile $603k–$9.4M
42CAP
VC Fund
1 Germany, France, Sweden Seed, Series A, Pre-Seed Software, Artificial Intelligence, SaaS $1.3M–$28M
4SC
VC Fund
1 Austria Seed Health Care, Biotechnology
EIT Health
VC Fund
1 United Kingdom, Spain, Ireland Grant, Pre-Seed, Seed Health Care, Medical Device, Medical $22k–$1.7M
Wlanholding GmbH
VC Fund
1 Austria Seed Medical, Health Care, Biotechnology
FastVentures
VC Fund
1 Hungary, South Korea, United States Seed, Series A, Series B Software, Biotechnology, Health Care $424k–$34M
Wellcome Trust
VC Fund
1 United States, United Kingdom, France Grant, Series C Biotechnology, Health Care, Medical $1.6M–$127M
Novartis Venture Fund
VC Fund
1 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$120M
Synthesis Capital
VC Fund
1 United States, Israel, Austria Seed, Series A, Series C Biotechnology, Food and Beverage, Organic Food $7.1M–$23M
HBM Partners
VC Fund
1 United States, Germany, Switzerland Series B, Series C Biotechnology, Medical, Health Care $2.5M–$125M
Amino Collective
VC Fund
1 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Biotechnology, Health Care, Artificial Intelligence $125k–$37M
Air Street Capital
VC Fund
1 United States, United Kingdom, France Seed, Series A, Series B Artificial Intelligence, Software, Biotechnology $2.6M–$300M
Andera Partners
VC Fund
1 France, United States, Germany Series B, Private Equity, Series A Biotechnology, Health Care, Medical $7M–$237M
Access all 191 investors in Austria Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

XISTA Science Ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 17 investments in Austria Biotech startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Germany, France

Investor stats

  • Total investments: 45
  • Round size: Seed $1.8M–$6.9M; Pre-Seed $511k–$2.3M; Series A $5.7M–$20M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • Ribbon Bio — Making The Impossible Possible
  • Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
  • G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
Show all investments...

tecnet equity
VC Fund · Sankt Polten, Niederosterreich, Austria · 9 investments in Austria Biotech startups

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: Austria

Investor stats

  • Total investments: 71
  • Round size: Seed $400k–$2.5M; Series A $583k–$20M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — last raise in 2009

Portfolio highlights

  • PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
  • Ribbon Bio — Making The Impossible Possible
  • Greenwood-Power — Greenwood-Power is the leading innovator for non-conventional transformers. Let's talk about your individual requirements - CONTACT US TODAY!
Show all investments...

xista science ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 9 investments in Austria Biotech startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Slovenia

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$7.3M; Pre-Seed $511k–$1.5M; Series A $5.7M–$20M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • subdron — subdron turns the seabed from a blind spot into a monitored domain.
  • infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

austria Wirtschaftsservice (aws)
VC Fund · Vienna, Wien, Austria · 6 investments in Austria Biotech startups, 8 in the past 12 months

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Austria, Belgium

Investor stats

  • Total investments: 70
  • Round size: Seed $439k–$2.8M; Grant $62k–$2.3M; Pre-Seed $195k–$1.6M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Repentium — We strive to create
  • Graph Therapeutics — Graph Therapeutics - precision immunology
  • Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 5 investments in Austria Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

MIG Capital
VC Fund · München, Bayern, Germany · 4 investments in Austria Biotech startups

MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: Germany, France, Austria

Investor stats

  • Total investments: 97
  • Round size: Series A $2.2M–$40M; Series B $1.6M–$60M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $70M in 2014

Portfolio highlights

  • NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
  • GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
  • Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
Show all investments...

aws Gründungsfonds
VC Fund · Vienna, Wien, Austria · 4 investments in Austria Biotech startups

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 91
  • Round size: Seed $1.3M–$5.2M; Series A $1.1M–$11M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • refinq — Our platform helps companies transform climate and biodiversity risks into opportunities to reduce costs, future-proof operations, and stay competitive.
  • vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
  • Invisible-Light Labs — Invisible Light Labs uses Fourier transform infrared (FTIR) spectroscopy and nanoelectromechanical sensing technologies to enable chemical analysis of materials and nanomaterials that are available in minuscule amounts in a variety of industries, from environmental monitoring to pharmaceuticals.
Show all investments...

FPS-Holding
VC Fund · 3 investments in Austria Biotech startups

Investment focus

  • Industry: Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 3
  • Round size: Seed $420k–$1.5M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
Show all investments...

Lansdowne Partners
VC Fund · London, England, United Kingdom · 3 investments in Austria Biotech startups

Fundamental Equity Investing, since 1998

Show more...

Investment focus

  • Industry: Biotechnology, Finance, Genetics
  • Stage:Series A, Series B
  • Geography: United Kingdom, Austria, United States

Investor stats

  • Total investments: 45
  • Round size: Series A $6.7M–$55M; Series B $8.5M–$100M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Nattergal — Nattergal delivers BNG Units and nature restoration at scale through rewilding, habitat creation and natural capital solutions.
  • MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
  • amnis — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
Show all investments...

Schnidar Harald
Angel · Vienna, Wien, Austria · 3 investments in Austria Biotech startups

Entrepreneur, Angel Investor, Scientist and Inventor

Show more...

Investment focus

  • Industry: mHealth, Software, Biopharma
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Austria

Investor stats

  • Total investments: 7
  • Lead/follow: 86% lead, 14% follow

Portfolio highlights

  • SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
PUSH VC
VC Fund · Vienna, Wien, Austria · 3 investments in Austria Biotech startups

We are an early-stage Venture Capital Firm investing in outstanding teams with convincing products and high growth potential.

Show more...

Investment focus

  • Industry: Software, Apps, Health Care
  • Stage:Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $650k–$8.1M; Series A $5M–$31M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Gustav — Modern staffing teams use Gustav's VMS to source talent from trusted sub-vendors. Fast, secure, and compliant!
  • Voltrac — Building electric autonomous vehicles for farming & frontline logistics
  • enspired — Revolutionize battery storage with AI-powered BESS optimization. Our energy trading platform ensures smart, real-time market access. Contact us today!
Show all investments...

10x Founders
VC Fund · Munich, Bayern, Germany · 3 investments in Austria Biotech startups, 7 in the past 12 months

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United States, Switzerland

Investor stats

  • Total investments: 92
  • Round size: Seed $2.5M–$10M; Pre-Seed $1.1M–$12M; Series A $6.7M–$60M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Logicc — Logicc provides business solutions for various industries. It specializes in software development, automation, and data-driven technologies.
  • Qorelo — Qorelo helps enterprise SAP teams accelerate S/4HANA migration, automate fit-gap analysis, map SAP scope, generate documentation, and guide continuous improvement after go-live.
  • Songscription — Play, learn & share the music you love. AI-powered audio transcription into sheet music, MIDI & piano roll for musicians, educators and creators.
Show all investments...

BackBone Ventures
VC Fund · Zurich, Zurich, Switzerland · 2 investments in Austria Biotech startups

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, Germany, Israel

Investor stats

  • Total investments: 74
  • Round size: Seed $966k–$4M; Pre-Seed $578k–$2.8M; Series A $5M–$105M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • eternal.ag — We help greenhouses overcome labor shortages through autonomous harvesting robots so they can keep operations running, every day, at scale.
  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • NextBusiness — NextBusiness makes tools for founders in Switzerland. We build the AI-first business software infinity.swiss.
Show all investments...

Verge HealthTech Fund
VC Fund · Singapore, Central Region, Singapore · 2 investments in Austria Biotech startups

We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging Asia​We believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Estonia, Singapore, United Kingdom

Investor stats

  • Total investments: 28
  • Round size: Seed $500k–$4.7M; Pre-Seed $500k–$1M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: May invest from a new fund soon — raised $17k in 2021

Portfolio highlights

  • Zoundream — The Future of Infant Care
  • Understanding Zoe — One calm home that remembers for you and grows with your family. Built in Australia for families raising neurodivergent children. Try free for 7 days.
  • Neuraworx Medical Technology — Neuraworx Medical Technology is a neurotechnology company developing first-in-class bioelectronic solutions for brain health.
Show all investments...

Simon Capital
VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups, 6 in the past 12 months

Simon Capital is an early-stage VC fund with €105M capital ready to invest in innovations that will improve our everyday lives, following the mission of investing “for the next generation”.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: Germany, Austria, The Netherlands

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$9.3M; Series A $1.7M–$14M; Series B $32M–$57M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $123M in 2022

Portfolio highlights

  • VisioLab — Instantly scan products for self-checkout, using the iPad camera - no barcodes needed. Designed for speed, simplicity and human centricity.
  • Pacifico Biolabs — Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of sustainable and food alternatives.
  • dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Austria Biotech startups, 12 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 95
  • Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and outcomes.
  • Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
  • Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 61
  • Round size: Seed $1.3M–$8M; Pre-Seed $511k–$9.1M; Series A $5.7M–$28M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • Jago Coffee — Jago Coffee serves freshly brewed coffee beverages wherever you are through a fleet of fully electric mobile cafes.
Show all investments...

KHAN Technology Transfer Fund
VC Fund · Dortmund, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups

KHAN Technology Transfer Fund operates as an investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Biopharma
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Austria, Luxembourg

Investor stats

  • Total investments: 14
  • Round size: Seed $259k–$10M; Series A $5.6M–$10M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
  • iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
  • KyDo Therapeutics — KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.
Show all investments...

Arax Capital Partners
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, SaaS
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 6
  • Round size: Seed $1.1M–$1.1M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
  • Greenpass — Greenpass is an all-in-one SaaS for climate-resilient urban planning & architecture platform that enables livable cities.
  • Calyxha Biotechnologies — A new perspective on inflammation
Show all investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway · 2 investments in Austria Biotech startups

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Norway, Sweden, Austria

Investor stats

  • Total investments: 32
  • Round size: Series A $4.3M–$79M; Series B $4.5M–$75M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — raised $105M in 2021

Portfolio highlights

  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
  • Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Longevitytech.fund
VC Fund · Prague, Hlavni mesto Praha, Czech Republic · 2 investments in Austria Biotech startups

Investing globally in technologies extending healthy lifespans

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 53
  • Round size: Seed $1.8M–$10M; Pre-Seed $100k–$3.6M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Whytics — DAGI: higher-level causal models from spatiotemporal coarse‑graining Whytics builds tools to reveal and validate macro‑causal structure—the stable, higher-level variables that appear when many parts of a system interact across space and time.
  • Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
  • Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
Show all investments...

red-stars.com
VC Fund · 2 investments in Austria Biotech startups

We back B2B software and life-sciences companies with limitless scalability.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Telecommunications
  • Stage:Seed, Series A
  • Geography: Austria, Germany

Investor stats

  • Total investments: 9
  • Round size: Seed $1.8M–$4.4M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • Txture — IBM Consulting uses IBM Txture to help organizations assess application portfolios, plan cloud modernization and build data-driven transformation strategies.
  • HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
  • MAVOCO — We create a carrier-grade software for IoT champions, trusted by tier-1 Mobile network operators.
Show all investments...

Ligand Pharmaceuticals
VC Fund · San Diego, California, United States · 2 investments in Austria Biotech startups

A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Post-IPO Debt, Corporate Round, Post-IPO Equity
  • Geography: United States, Austria, Denmark

Investor stats

  • Total investments: 19
  • Round size: Post-IPO Debt $15M–$85M; Corporate Round $3M–$10M; Post-IPO Equity $15M–$90M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • Agenus — Activating the Power of the Immune System to Defeat Cancer
  • Zerion Pharma — Zerion Pharma is a pharmaceutical company that aims to transform the pharmaceutical landscape with a new formulation technology. The company is focused on improving existing drugs by building an internal pipeline to solve the most challenging drug solubility problems that pharmaceutical companies face. Zerion Pharma was founded in 2019 and isbased in Birkerød, Denmark.
  • Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
Show all investments...

The Austrian Research Promotion Agency (FFG)
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Medical
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Austria, United States, Belgium

Investor stats

  • Total investments: 70
  • Round size: Seed $300k–$2.2M; Grant $67k–$3.5M; Pre-Seed $480k–$1.9M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
  • sequestra — Sequestra is developing a technology platform that allows for permanent binding of CO₂ in industrial residues such as steel slag, incineration ash, and demolition waste while making the carbonated materials usable for construction applications.
  • Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
Show all investments...

ICL Planet Startup Hub
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Austria Biotech startups

ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration

Show more...

Investment focus

  • Industry: Biotechnology, Agriculture, AgTech
  • Stage:Seed
  • Geography: Israel, Austria

Investor stats

  • Total investments: 4
  • Round size: Seed $4.3M–$10M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Agrematch — Agrematch is a data driven small molecules product discovery, development and marketing company, catering to the agricultural industry. Our novel Ag products discovery engine utilizes big-data science, biology, chemistry, and ag know-how to bring new crop protection products to market.
  • Lavie bio — LaVie Bio develops bacterial compositions that are sprayed on plants, used to coat seeds, or are integrated in the soil around the plant in order to improve the crop or the plant's features.
  • Arkeon Biotechnologies — Arkeon converts CO2 into resources to power tomorrow's industries.
Show all investments...

R42 Group
VC Fund · Stanford, California, United States · 2 investments in Austria Biotech startups

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Austria

Investor stats

  • Total investments: 35
  • Round size: Seed $754k–$8M; Pre-Seed $472k–$2M; Series A $4.2M–$40M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • Stamp Free — stampfree.ai Digital Shipping Solutions enables customers to send parcels and returns with just a phone conveniently and securely.
  • Cordance Medical — Improving outcomes for patients with brain diseases
Show all investments...

bmp Ventures
VC Fund · Berlin, Berlin, Germany · 2 investments in Austria Biotech startups, 6 in the past 12 months

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Germany, United States, Austria

Investor stats

  • Total investments: 120
  • Round size: Seed $165k–$3.4M; Series A $30k–$5.9M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
  • Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
  • Litherm Technologies — Fully electric calcination as a pathway to zero-emission lime and cement production.
Show all investments...

Open Field Capital
VC Fund · New York, New York, United States · 2 investments in Austria Biotech startups

Open Field Capital

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Series A, Seed
  • Geography: United States, Austria, United Kingdom

Investor stats

  • Total investments: 21
  • Round size: Seed $3.1M–$30M; Series A $8.7M–$52M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Numenta — Powerful, Neuroscience-Based AI
  • Paragraf — We Work to Develop Innovative and Useful End Products from Novel Materials. Our Analogue Sensors Are Designed to Provide Accurate Field Gradient Mapping & Alignment.
  • Mojo Vision — Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today'smobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree.Mojo Vision was founded in 2015 and headquartered in Saratoga, California.
Show all investments...

Übermorgen Ventures
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotech startups

We are an early stage VC for climate tech startups.

Show more...

Investment focus

  • Industry: Energy, Software, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Switzerland, Finland

Investor stats

  • Total investments: 55
  • Round size: Seed $2.1M–$5.9M; Pre-Seed $300k–$4.1M; Series A $2.5M–$12M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Ecair — Ecair provides software for indoor air quality and energy management. The platform aggregates data from connected sensors to track pollutants, CO2, humidity, temperature, and particulate matter in real time. Dashboards, alerts, and APIs support building operations, facility managers, and ESG teams. Algorithms estimate exposure, flag ventilationissues, and suggest HVAC adjustments to balance comfort, health, and energy use. Reporting tools support certifications and compliance, and data exports integrate with BMS, CMMS, and data warehouses. Services include device provisioning, calibration management, and analytics consulting for multi-site portfolios.
  • Verna — Verna is a business using geospatial data science to address the climate and nature crises.We help landowners, investors, and policymakers to use land in ways that draw down carbon, enhance biodiversity and generate sustainable returns – e.g. through woodland creation, habitat creation and enhancement, and regenerative agriculture.Verna wasestablished in Borehamwood, Hertford.
  • Hyperion Robotics — We are accelerating the transition to sustainable and automated construction with Concrete 3D Printing.
Show all investments...

Aescap Venture
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Austria Biotech startups

Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Chemical
  • Stage:Series A, Series B
  • Geography: United Kingdom, Austria, Belgium

Investor stats

  • Total investments: 18
  • Round size: Series A $1.5M–$20M; Series B $5.2M–$33M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
  • Affectis Pharmaceuticals — Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.
  • F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
TSVC
VC Fund · Los Altos, California, United States · 2 investments in Austria Biotech startups, 14 in the past 12 months

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 293
  • Round size: Seed $500k–$7M; Series A $2.7M–$55M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Dexmate — Dexmate is a robotics startup focused on developing general-purpose mobile robots. The company specializes in robots with manipulation capabilities. Their technology aims to enhance automation across various industries.
  • EGI Battery — EGI Battery is an American advanced battery cell manufacturer headquartered with design and operations in Ann Arbor, Michigan, U.S.
  • Expert Intelligence — Expert Intelligence develops AI systems to scale expert decision-making in regulated laboratory conditions where data is restricted, stakes are high, and validation is required.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 610
  • Round size: Seed $909k–$7M; Series A $3.5M–$39M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $522M in 2022

Portfolio highlights

  • CorTec — Reliable products for active implantable device development. We realize your next project with you and offer individual solutions that meet your specific requirements for Medical Devices, especially in neurotechnology.
  • Coinlend — Coinlend - The Lending-Bot for Bitfinex & Liquid Genearate interest from your Bitcoin and Altcoin investments!
  • CenterPoint - Connective Software Engineering — CenterPoint was founded in 2000 and is based in Villach, Austria with an additional office in Warsaw, Poland. CenterPoint - Connective Software Engineering develops and markets process control and fault detection and classification software solutions. The company offers cause effect analysis, metrology assessment, and close loop and run to runcontrol services. It's focus are the semiconductors, electronics, and steel and alloy industries.
Show all investments...

Gamma Capital Partners
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Seed
  • Geography: Austria, United States, Germany

Investor stats

  • Total investments: 29
  • Round size: Seed $406k–$636k; Series A $1.3M–$8M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Icomasoft — Icomasoft ag is a Swiss pioneer of agent-less software solutions providing unprecedented transparency across your virtual and physical IT infrastructure in heterogeneous datacenters.IcomasoftÂ:registered: software solutions collect essential information for mission-critical and business-critical decisions and provide simplified, automated tasksthat support administrators, IT managers and Executives to easily and confidently analyze, plan and optimize their IT capacity. icomasoftÂ:registered: software solutions are vital for your datacenter clarity.
  • Henn GmbH & Co KG — A connection system manufacturer in Austria. High-quality VDA/SAE couplings for charge air cooling water systems used by OEMs worldwide
  • CNSystems Medizintechnik — Non-invasive, continuous blood pressure & hemodynamics: cardiovascular assessment (syncope), hypotension & fluid management (CNAP technology)
Show all investments...

SkyGene
VC Fund · Austria, Pangasinan, Philippines · 2 investments in Austria Biotech startups

SkyGene is a venture capital firm. The firm intends to invest in biotech firms.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

GreyBird Ventures
VC Fund · Concord, Massachusetts, United States · 2 investments in Austria Biotech startups

GreyBird Ventures medical technology firm and invests in companies developing products for precision medicine.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 9
  • Round size: Series A $3M–$16M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • NeuroKaire — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
  • Platomics — Platomics provides a regulatory compliant digital infrastructure and network for every laboratory to setup and run genetic tests.
  • Angstrom Bio — We Apply Machine Learning And Novel Nucleotide Chemistry to the Diagnosis and Treatment Of Disease. Unparalleled Diagnostic Scale. Better Drugs, Faster.
Show all investments...

VP Venture Partners
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotech startups

VP Venture Partners is a venture capital firm invests in healthcare companies.

Show more...

Investment focus

  • Industry: Medical, Health Diagnostics, Internet
  • Stage:Seed
  • Geography: Austria, Switzerland

Investor stats

  • Total investments: 7
  • Round size: Seed $3M–$6.9M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Moonlight AI — Moonlight AI was created to democratize the access to genomic information that is essential for therapy decision making in the era of personalized medicine.
  • CollimateHealth — CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer.
Show all investments...

eQventure
VC Fund · Graz, Steiermark, Austria · 2 investments in Austria Biotech startups

Entrepreneurs for Entrepreneurs

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: Austria, Germany, Switzerland

Investor stats

  • Total investments: 60
  • Round size: Seed $540k–$1.2M; Series A $768k–$6.3M
  • Lead/follow: 77% lead, 23% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
  • 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
Show all investments...

MCI Capital SA
VC Fund · Warsaw, Mazowieckie, Poland · 1 investments in Austria Biotech startups

MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically investsEUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing.MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.

Show more...

Investment focus

  • Industry: E-Commerce, Software, Mobile
  • Stage:Series A, Seed
  • Geography: Poland, Germany, United Kingdom

Investor stats

  • Total investments: 41
  • Round size: Seed $1.1M–$1.5M; Series A $603k–$9.4M
  • Lead/follow: 73% lead, 27% follow

Portfolio highlights

  • IdoSell — IdoSell Shop is a complex service available in SaaS model directed to professional online shops and wholesale stores.
  • Gett — Gett is a technology platform focused on corporate Ground Transportation Management (GTM), where spend is estimated to exceed $100 billion globally. https://gett.com/why We are the GTM category leader, serving over a quarter of the Fortune 500 companies.Gett’s cloud-based software organizes thousands of transportation providers(corporate fleet, ride-hailing, taxi, and limos) into one single platform. The technology helps save businesses time and money by managing all their ground transportation spend, and optimizes the entire employee experience from booking and riding to invoicing and analytics.We are building the first ground transportation grid available to customers worldwide, similar to telephony and internet grids, with aspirations to become the standard in corporate ground transportation, just as Zoom became the standard in corporate communication.Founded in 2010 and headquartered in London, Gett has raised more than $750M in funding to date, including more than $300M from the Volkswagen Group. They employ over 800 employees globally.
  • ANSWEAR.com
Show all investments...

42CAP
VC Fund · Munich, Bayern, Germany · 1 investments in Austria Biotech startups

We are peers amongst entrepreneurs helping the brave to build game-changing companies, just like we have done ourselves.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, France, Sweden

Investor stats

  • Total investments: 100
  • Round size: Seed $2.2M–$6M; Pre-Seed $1.3M–$2.3M; Series A $2.3M–$28M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • ALP Bio — Alp Bio’s platform integrates tonsil organoid technology with advanced protein AI to identify and mitigate immunogenic risks in therapeutic antibodies, ensuring safer patient outcomes.
  • Flowlity — Flowlity revolutionizes planners' experience by streamlining tasks within planning tools and automating 95% of planning activities.
  • ARC Intelligence — ARC Intelligence operates as a supplier of data systems driven by AI for small and medium-sized businesses.
Show all investments...

4SC
VC Fund · Planegg, Bayern, Germany · 1 investments in Austria Biotech startups

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Panoptes Pharma — PETIRGACOR open Online Apotheke menyediakan layanan pemesanan medikamente resmi dengan pengiriman cepat ke seluruh Deutschland. Cek promo obat hari ini!
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
EIT Health
VC Fund · Munich, Bayern, Germany · 1 investments in Austria Biotech startups

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Grant, Pre-Seed, Seed
  • Geography: United Kingdom, Spain, Ireland

Investor stats

  • Total investments: 100
  • Round size: Seed $220k–$1.4M; Grant $22k–$1.7M; Pre-Seed $44k–$1.7M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • IDOVEN — Idoven has developed the world’s first AI cardiologist -Willem- that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale through APIs. The company counts clients such as AstraZeneca, Abbott, Novartis, GE Healthcare, FIFPRO, Google, Santander and Real Madrid Foundation.Idoven is backed by top-tier investors and business angels including Insight Partners, Northzone and Wayra (Telefónica), Iker Casillas, Pau Gasol, the Accel Starters program, EIC Accelerator, Horizon 2020, ERC and EIT Health. The company has been awarded with numerous distinctions for its AI technology in Europe and the US, including the the European Seal of Excellence 3x from the European Commission, granted by Horizon 2020, European Research Council ERC 2x (RIA) Europe’s most prestigious research grant, supporting excellent researchers in carrying out ground-breaking, high-risk, high-gain, frontier research projects, EIC Accelerator, and EIT Health. Idoven was ranked #1 Spanish HealthTech company in 2020 by NEOTEC. Idoven has been Google for Startups Resident at Google Campus Madrid and part of the Google for Startups Global Alumni Program. The company has won the prize Emprendedor XXI from CaixaBank, the Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine, and has been awarded at South Summit 2021 as the Most Disruptive Startup, and Best Health and Wellbeing Startup. Selected by CB Insights as one of the top 150 global companies in Digital Health for 2022, and top 50 global companies in Digital Health for 2023. Idoven was recognized by TIME Magazine as one of the World's Top HealthTech Companies of 2025.
  • Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
  • Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Show all investments...

Wlanholding GmbH
VC Fund · 1 investments in Austria Biotech startups

Led by Werner Lanthaler, Wlanholding invests in life sciences and sustainability, advancing innovation and growth in cutting-edge technologies.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
Show all investments...

FastVentures
VC Fund · Budapest, Budapest, Hungary · 1 investments in Austria Biotech startups

venture capital

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Hungary, South Korea, United States

Investor stats

  • Total investments: 28
  • Round size: Seed $424k–$34M; Series A $1.3M–$2.3M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Cytocast — Imagine a world where new therapies can be discovered and developed in a fraction of what it takes now.
  • Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
  • On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
Show all investments...

Wellcome Trust
VC Fund · London, England, United Kingdom · 1 investments in Austria Biotech startups, 9 in the past 12 months

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Grant, Series C
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 124
  • Round size: Grant $1.6M–$10M; Series C $10M–$127M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $319M in 2018

Portfolio highlights

  • Lario Therapeutics — Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
  • Wysa — Use Wysa to vent or just talk through negative thoughts and emotions. Let it help you cope with pandemic anxiety and lockdowns. It is anonymous, safe and free.
  • Ineffable Intelligence — Ineffable Intelligence develops machine learning systems that learn through interaction and experience. The company works on reinforcement learning approaches that allow models to improve by trial and error rather than relying on large human-generated datasets. Its core work centers on building a “superlearner,” a system designed to generateknowledge and skills by engaging with simulated or real environments.The organization develops algorithms and computational frameworks that support autonomous learning, experimentation, and decision-making processes. Its efforts involve designing AI models that can adapt, refine behavior, and solve complex problems through continuous feedback loops. The company’s research aims to expand how AI systems acquire knowledge and apply it across different domains.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in Austria Biotech startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 213
  • Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
  • Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
  • LOQUS23 THERAPEUTICS — LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease and other triplet repeat diseases.
Show all investments...

Synthesis Capital
VC Fund · London, England, United Kingdom · 1 investments in Austria Biotech startups

Synthesis Capital is an investment manager transforming our food system through food technology.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Organic Food
  • Stage:Seed, Series A, Series C
  • Geography: United States, Israel, Austria

Investor stats

  • Total investments: 10
  • Round size: Seed $7.1M–$9M; Series A $20M–$23M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Triplebar — Triplebar provides sustainability, biotechnology, and synthetic biology research.
  • Savor — Savor makes delightfully rich foods without animals, farmland, fertilizers, hormones, or antibiotics.
  • Culture Biosciences — Culture Biosciences develops automated bio-reactor that helps biotech companies optimize their manufacturing processes and brings products to market faster. The company also builds automated tools for fermentation. It has a digital bio-manufacturing platform to enable scientists to run, monitor, and analyze bio-reactors faster than traditionalapproaches by robotic sample handling and cloud data monitoring and analysis.Culture Biosciences was founded in 2016 and is headquartered in San Francisco, California.
Show all investments...

HBM Partners
VC Fund · Zug, Zug, Switzerland · 1 investments in Austria Biotech startups

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series B, Series C
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 41
  • Round size: Series B $7.7M–$125M; Series C $2.5M–$113M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $105M in 2012

Portfolio highlights

  • Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
  • AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
  • Mineralys Therapeutics — Evolving science is revealing the importance of aldosterone in cardio-renal-metabolic diseases.We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone. About Aldosterone
Show all investments...

Amino Collective
VC Fund · Berlin, Berlin, Germany · 1 investments in Austria Biotech startups

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 45
  • Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
  • Modern Relay — Modern Relay provides context graph for enterprise AI.
  • Theorema — Autonomous R&D agents for biotech, pharma, chemicals, and materials. Theorema analyzes data, recovers R&D costs, and accelerates discovery. #1 on BixBench.
Show all investments...

Air Street Capital
VC Fund · London, England, United Kingdom · 1 investments in Austria Biotech startups

Air Street Capital provides venture capital funding and strategic support focused on early-stage companies that develop products based on artificial intelligence. It invests primarily at pre-seed, seed, and Series A stages in firms working on AI-first technology, software infrastructure, machine-learning tools, and AI-enabled life scienceapplications. The firm pairs capital investment with advisory input on product, market, and technology strategy, and facilitates connections to its broader network of AI and technology stakeholders. Air Street Capital also shares industry insights through publications and community initiatives aimed at supporting AI and related tech ecosystems.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 48
  • Round size: Seed $2.6M–$14M; Series A $14M–$48M; Series B $64M–$300M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • STARK — EUROPEAN DEFENCE SOVEREIGNTY
  • Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
  • Macrodata Labs — Reviewing and annotating robotics data by hand does not scale. Macrodata Labs automates QA, subtask annotation, 3D hand tracking, and reward scoring across large robot and egocentric datasets. Send a few sample episodes for a free demo.
Show all investments...

Andera Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Austria Biotech startups, 12 in the past 12 months

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Private Equity, Series A
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 185
  • Round size: Series A $7M–$83M; Series B $14M–$85M; Private Equity $110M–$237M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $466M in 2022

Portfolio highlights

  • Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
  • Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
  • Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
Show all investments...

Biotech Investor funding in Austria at a glance

Stats across 166 deals from 191 investors.

191
investors
in Austria Biotech startups
166
deals
in Austria Biotech startups
$3.2M
median round
in Austria Biotech startups
48%
lead investors
lead at least one round
29%
Seed
most common funding stage
96/4
VC / Angel
share of investor count

Access all 191 investors in Austria Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 191 investors investing in Austria Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists